Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Price

Showing results (221-230 of 261) with videos related to

Pageof 27
Sort By:
JACC. Heart Failure|July 27, 2025
Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation With Extended Non-COAPT-Like Features: From the EXPANDed StudiesGilbert H L Tang, Matthew J Price, Wolfgang Rottbauer, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|March 14, 2009
Safety and performance of targeted renal therapy: the Be-RITe! RegistryGiora Weisz, Steven J Filby, Mauricio G Cohen, et al.
JACC. Clinical Electrophysiology|February 4, 2025
Tricuspid Transcatheter Edge-to-Edge Repair in Patients With Transvalvular CIED Leads: The TRILUMINATE Pivotal TrialHursh Naik, Matthew J Price, Samir Kapadia, et al.
American Heart Journal|June 5, 2017
Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trialFreddy Abnousi, Vandana Sundaram, Celina M Yong, et al.
JACC. Cardiovascular Interventions|June 28, 2023
Expanding the Spectrum of TEER Suitability: Evidence From the EXPAND G4 Post Approval StudyJason H Rogers, Federico Asch, Paul Sorajja, et al.
Journal of Thrombosis and Thrombolysis|November 18, 2015
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomesJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
European Heart Journal|June 5, 2025
Optical coherence tomography- vs angiography-guided coronary stent implantation in calcified lesions: the ILUMIEN IV trialZiad A Ali, Doosup Shin, Rajesh Vijayvergiya, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 7, 2023
Two-year results from Onyx ONE clear in patients with high bleeding risk on one-month DAPT with and without intracoronary imagingGabor G Toth, David E Kandzari, Ajay J Kirtane, et al.
Circulation. Cardiovascular Interventions|January 21, 2026
Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair: Results From the EXPANDed StudiesMark J Ricciardi, Gagan Singh, Jason H Rogers, et al.
Journal of the American College of Cardiology|September 11, 2010
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphateLaurent Bonello, Udaya S Tantry, Rossella Marcucci, et al.
Pageof 27

Showing results (221-230 of 261) with videos related to

Sort By:
Pageof 27
JACC. Heart Failure|July 27, 2025
Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation With Extended Non-COAPT-Like Features: From the EXPANDed StudiesGilbert H L Tang, Matthew J Price, Wolfgang Rottbauer, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|March 14, 2009
Safety and performance of targeted renal therapy: the Be-RITe! RegistryGiora Weisz, Steven J Filby, Mauricio G Cohen, et al.
JACC. Clinical Electrophysiology|February 4, 2025
Tricuspid Transcatheter Edge-to-Edge Repair in Patients With Transvalvular CIED Leads: The TRILUMINATE Pivotal TrialHursh Naik, Matthew J Price, Samir Kapadia, et al.
American Heart Journal|June 5, 2017
Cangrelor reduces the risk of ischemic complications in patients with single-vessel and multi-vessel disease undergoing percutaneous coronary intervention: Insights from the CHAMPION PHOENIX trialFreddy Abnousi, Vandana Sundaram, Celina M Yong, et al.
JACC. Cardiovascular Interventions|June 28, 2023
Expanding the Spectrum of TEER Suitability: Evidence From the EXPAND G4 Post Approval StudyJason H Rogers, Federico Asch, Paul Sorajja, et al.
Journal of Thrombosis and Thrombolysis|November 18, 2015
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomesJessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
European Heart Journal|June 5, 2025
Optical coherence tomography- vs angiography-guided coronary stent implantation in calcified lesions: the ILUMIEN IV trialZiad A Ali, Doosup Shin, Rajesh Vijayvergiya, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 7, 2023
Two-year results from Onyx ONE clear in patients with high bleeding risk on one-month DAPT with and without intracoronary imagingGabor G Toth, David E Kandzari, Ajay J Kirtane, et al.
Circulation. Cardiovascular Interventions|January 21, 2026
Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair: Results From the EXPANDed StudiesMark J Ricciardi, Gagan Singh, Jason H Rogers, et al.
Journal of the American College of Cardiology|September 11, 2010
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphateLaurent Bonello, Udaya S Tantry, Rossella Marcucci, et al.
Pageof 27